ABT
Abbott Laboratories
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: ABT
- PEG Ratio
ABT's PEG ratio is unavailable because the earnings growth data is negative or zero. Historical data from September 2025 indicates Abbott Laboratories with a PEG ratio of 0.12.
ABT PEG ratio history
Abbott Laboratories's nine years historical PEG ratio has an average of 2.28. ABT reached its maximum PEG ratio of 26.04 during the Sep 2020 quarter over the past nine years. The Mar 2019 quarter had the bottom reading at 0.11, indicating the most optimal growth-adjusted valuation.
Abbott Laboratories PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | N/A | 33.59 | -51.4% |
| 2024 | 0.11 | 14.75 | 133.8% |
| 2023 | N/A | 33.56 | -16.8% |
| 2022 | N/A | 27.87 | -0.8% |
| 2021 | 0.62 | 35.45 | 57.5% |
| 2020 | 2 | 43.45 | 21.7% |
| 2019 | 0.77 | 41.96 | 54.5% |
| 2018 | 0.14 | 53.98 | 396.3% |
| 2017 | N/A | 211.37 | -71.3% |
| 2016 | N/A | 40.86 | -68% |
| 2015 | 0.16 | 15.28 | 96% |
| 2014 | N/A | 30.01 | -8.5% |
| 2013 | N/A | 23.37 | -56.4% |
| 2012 | 0.72 | 17.42 | 24.1% |
| 2011 | 10.92 | 18.56 | 1.7% |
Abbott Laboratories PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | N/A | 28.6 | -53.5% |
| Dec 2025 | N/A | 33.59 | -51.4% |
| Sep 2025 | 0.12 | 16.74 | 142.4% |
| Jun 2025 | 0.11 | 17 | 151.6% |
| Mar 2025 | 0.12 | 17.18 | 139% |
| Dec 2024 | 0.11 | 14.75 | 133.8% |
| Sep 2024 | 2.9 | 34.55 | 11.9% |
| Jun 2024 | 4.19 | 32.68 | 7.8% |
| Mar 2024 | N/A | 35.19 | -2.4% |
| Dec 2023 | N/A | 33.56 | -16.8% |
| Sep 2023 | N/A | 32.83 | -34% |
| Jun 2023 | N/A | 36.96 | -38.9% |
| Mar 2023 | N/A | 30.59 | -23.9% |
| Dec 2022 | N/A | 27.87 | -0.8% |
| Sep 2022 | 2.14 | 21.65 | 10.1% |
ABT average PEG ratio chart
PEG comparison
ABT EPS growth
ABT Price vs fair value
ABT PEG vs peers
| Stock name | PEG ratio | Market cap |
|---|---|---|
| BSX Boston Scientific Corp | 0.25 | $65.89B |
| BMY Bristol Myers Squibb Co | 0.46 | $111.7B |
| AZN Astrazeneca plc | 0.78 | $273.29B |
| NVS Novartis AG | 2.31 | $284.17B |
| TMO Thermo Fisher Scientific Inc | 3.86 | $172.44B |
| MDT Medtronic plc | 6.41 | $101.47B |
| JNJ Johnson & Johnson | N/A | $556.77B |
| PFE Pfizer Inc | N/A | $142.94B |
| ABT Abbott Laboratories | N/A | $152.98B |
Frequently asked questions
What is Abbott Laboratories's PEG ratio?
ABT's PEG ratio is unavailable because EPS growth data is negative or not present.
What is the 3-year average PEG ratio for Abbott Laboratories (ABT)?
Over the last 3 years, ABT's PEG ratio has settled near 1.26.
What is the 5-year average PEG ratio for Abbott Laboratories (ABT)?
Over the last 5 years, ABT's PEG ratio has settled near 1.02.
What is the highest PEG ratio for ABT?
The Sep 2020 quarter marked the nine years high at 26.04 for ABT's PEG ratio.
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.